Hypera (FRA:HM6A) Total Liabilities: €1,965 Mil (As of Mar. 2026)


FRA:HM6A Hypera SA FRA:HM6A
92 GF Score
Price €3.38
GF Value €5.13
! 4 Warning Signs
View Full Analysis

What is Hypera Total Liabilities?

Hypera FRA:HM6A -0.59% 92 Total Liabilities is €1,965 Mil as of Mar. 2026. GuruFocus rates FRA:HM6A with a GF Score™ of 92/100 and a GF Value™ of €5.13. The stock has 4 warning signs investors should review.

Hypera's Total Liabilities for the quarter that ended in Mar. 2026 was €1,965 Mil.

Hypera's quarterly Total Liabilities declined from Sep. 2025 (€2,049.15 Mil) to Dec. 2025 (€1,977.59 Mil) and declined from Dec. 2025 (€1,977.59 Mil) to Mar. 2026 (€1,964.69 Mil).

Hypera's annual Total Liabilities declined from Dec. 2023 (€2,431.25 Mil) to Dec. 2024 (€1,949.96 Mil) but then increased from Dec. 2024 (€1,949.96 Mil) to Dec. 2025 (€1,977.59 Mil).

Hypera Total Liabilities Historical Data

* Premium members only.

The historical data trend for Hypera's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hypera Total Liabilities Chart

Hypera Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,562.59 2,357.61 2,431.25 1,949.96 1,977.59

Hypera Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,022.09 1,914.04 2,049.15 1,977.59 1,964.69
FRA:HM6A
92GF Score
Hypera SA FRA:HM6A
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hypera Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Hypera's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=643.504+(1253.449+77.321
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+3.313)
=1,978

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=3938.071-1960.485
=1,978

Hypera's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=568.043+(1310.216+83.39
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+3.313)
=1,965

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=4300.69-2336.001
=1,965

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €1,965 Mil mean?
Hypera (FRA:HM6A) has a Total Liabilities of €1,965 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Hypera and its competitors.
Is Hypera's Total Liabilities too high?
Hypera's current Total Liabilities is €1,965 Mil. Overall, Hypera has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does Hypera's Total Liabilities compare to ZTS and UTHR?
Hypera's Total Liabilities of €1,965 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Hypera and its competitors. Hypera's current Total Liabilities is €1,965 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hypera stock overvalued right now?
Hypera (FRA:HM6A) has a current Total Liabilities of €1,965 Mil. The stock's GF Value™ is €5.13, compared to a current price of €3.38 — trading 34.1% below its estimated fair value. The current Total Liabilities is €1,965 Mil. Hypera's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Hypera (FRA:HM6A), the current Total Liabilities is €1,965 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hypera (FRA:HM6A) Overvalued in 2026?

Based on GuruFocus' analysis, Hypera stock appears to be undervalued. The current stock price of €3.38 is trading 34.1% below its estimated GF Value™ of €5.13.

Key valuation signals for FRA:HM6A:

  • Total Liabilities: €1,965 Mil
  • GF Value™: €5.13 vs. price of €3.38 (34.1% below fair value)
  • GF Score™: 92/100 with 4 warning signs

No single metric tells the full story. See the FRA:HM6A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hypera Business Description

Address Avenida Magalhaes de Castro, 4800, 240 Floor Continental Tower Building, Bairro Cidade Jardim, Sao Paulo, SP, BRA, CEP 05676-120
Hypera SA is a specialty and generic drug manufacturing company. The company operates in the prescription medicines, over-the-counter (OTC) medicines, branded generics, and generics, and skincare segments within the retail pharmaceutical market. The company also has a wide sales and distribution structure. The company's product portfolio includes key brands in Gastroenterology, Pain, Sun Protection, Skin Moisture, and Cleansing within the over-the-counter (OTC) and Skincare segments, as well as new products in Cardiology, Central Nervous System, and Respiratory System within the prescription medicines segment.
92GF Score

Get the complete analysis for FRA:HM6A

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.38
Price
€5.13
GF Value